Taiwan · Delayed Price · Currency is TWD Foresee Pharmaceuticals Statistics
Total Valuation
TPEX:6576 has a market cap or net worth of TWD 12.45 billion. The enterprise value is 11.95 billion.
| Market Cap | 12.45B |
| Enterprise Value | 11.95B |
Important Dates
The next estimated earnings date is Tuesday, May 19, 2026.
| Earnings Date | May 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6576 has 157.54 million shares outstanding. The number of shares has increased by 12.80% in one year.
| Current Share Class | 157.54M |
| Shares Outstanding | 157.54M |
| Shares Change (YoY) | +12.80% |
| Shares Change (QoQ) | +1.97% |
| Owned by Insiders (%) | 8.51% |
| Owned by Institutions (%) | 1.15% |
| Float | 109.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 31.03 |
| PB Ratio | 8.92 |
| P/TBV Ratio | 9.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -65.27 |
| EV / Sales | 29.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.39 |
Financial Position
The company has a current ratio of 13.61, with a Debt / Equity ratio of 0.29.
| Current Ratio | 13.61 |
| Quick Ratio | 10.94 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.51 |
| Interest Coverage | -112.66 |
Financial Efficiency
Return on equity (ROE) is -13.45% and return on invested capital (ROIC) is -27.17%.
| Return on Equity (ROE) | -13.45% |
| Return on Assets (ROA) | -24.41% |
| Return on Invested Capital (ROIC) | -27.17% |
| Return on Capital Employed (ROCE) | -38.46% |
| Weighted Average Cost of Capital (WACC) | 7.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.22 |
| Inventory Turnover | 0.90 |
Taxes
In the past 12 months, TPEX:6576 has paid 30.69 million in taxes.
| Income Tax | 30.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.67% in the last 52 weeks. The beta is 0.67, so TPEX:6576's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +22.67% |
| 50-Day Moving Average | 78.91 |
| 200-Day Moving Average | 79.66 |
| Relative Strength Index (RSI) | 47.42 |
| Average Volume (20 Days) | 198,384 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6576 had revenue of TWD 401.12 million and -183.13 million in losses. Loss per share was -1.38.
| Revenue | 401.12M |
| Gross Profit | 261.62M |
| Operating Income | -712.55M |
| Pretax Income | -152.45M |
| Net Income | -183.13M |
| EBITDA | -669.93M |
| EBIT | -712.55M |
| Loss Per Share | -1.38 |
Balance Sheet
The company has 891.98 million in cash and 399.26 million in debt, with a net cash position of 492.72 million or 3.13 per share.
| Cash & Cash Equivalents | 891.98M |
| Total Debt | 399.26M |
| Net Cash | 492.72M |
| Net Cash Per Share | 3.13 |
| Equity (Book Value) | 1.39B |
| Book Value Per Share | 6.86 |
| Working Capital | 1.14B |
Cash Flow
In the last 12 months, operating cash flow was -729.82 million and capital expenditures -47.09 million, giving a free cash flow of -776.91 million.
| Operating Cash Flow | -729.82M |
| Capital Expenditures | -47.09M |
| Depreciation & Amortization | 50.13M |
| Net Borrowing | -64.05M |
| Free Cash Flow | -776.91M |
| FCF Per Share | -4.93 |
Margins
Gross margin is 65.22%, with operating and profit margins of -177.64% and -45.66%.
| Gross Margin | 65.22% |
| Operating Margin | -177.64% |
| Pretax Margin | -38.00% |
| Profit Margin | -45.66% |
| EBITDA Margin | -167.01% |
| EBIT Margin | -177.64% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6576 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.80% |
| Shareholder Yield | -12.80% |
| Earnings Yield | -1.47% |
| FCF Yield | -6.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |